-
Product Insights
NewInfluenza A Virus, H3N2 Subtype Infections – Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H3N2 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. H3N2 infections are caused by variant H3N2 virus, which is a strain of influenza. Symptoms include cough, sore throat, runny or stuffy nose, chills, nausea, vomiting, and/or diarrhea. Risk factors include age and chronic medical conditions like asthma, diabetes, heart disease, weakened immune systems, and neurological or neurodevelopment conditions. Treatment includes antiviral medications and antibiotics. The Influenza A...
-
Product Insights
NewPeanut Allergy – Drugs In Development, 2024
Empower your strategies with our Peanut Allergy – Drugs In Development, 2024 report and make more profitable business decisions. Peanut allergy is common, especially in children. An allergic response to peanuts usually occurs within minutes after exposure, and symptoms range from mild to severe. Peanut allergy signs and symptoms can include skin reactions such as hives, redness or swelling; itching or tingling in or around the mouth and throat; digestive problems, such as diarrhea, stomach cramps, nausea or vomiting; tightening of...
-
Product Insights
NewPrimary Immune Deficiency (PID) – Drugs In Development, 2024
Empower your strategies with our Primary Immune Deficiency (PID) – Drugs In Development, 2024 report and make more profitable business decisions. Primary immune deficiency (PID) is defined as weakened immune system, allowing repeated infections and other health problems to occur more easily. Signs and symptoms include blood infections, pneumonia, bronchitis, sinus infections, ear infections, meningitis or skin infections, and digestive problems such as cramping, loss of appetite, nausea, and diarrhea. The Primary Immune Deficiency (PID) drugs in development market research report...
-
Product Insights
NewAvian Influenza – Drugs In Development, 2024
Empower your strategies with our Avian Influenza – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza, commonly referred to as bird flu, is a viral infection that primarily affects birds, especially poultry such as chickens and turkeys. Various strains of avian influenza viruses exist, some of which can cause severe illness in birds and, in certain cases, pose a risk to human health. Avian influenza viruses belong to the influenza A virus family and are classified...
-
Product Insights
NewHouse Dust Mite Allergy – Drugs In Development, 2024
Empower your strategies with our House Dust Mite Allergy – Drugs In Development, 2024 report and make more profitable business decisions. House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include frequent sneezing, a runny, stuffy, itchy nose, and irritated eyes. Asthma and eczema can also be triggered by a dust mite allergy. Symptoms often worsen when the individual comes in close proximity to disturbed dust. The predisposing factors include family history...
-
Product Insights
NewGrass Pollen Allergy – Drugs In Development, 2024
Empower your strategies with our Grass Pollen Allergy – Drugs In Development, 2024 report and make more profitable business decisions. Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions such as hives, redness, or swelling; itching or tingling in or around the mouth and throat; tightening of the throat; shortness of breath or wheezing; and runny nose. Predisposing factors include age, family history, and other allergies. The Grass Pollen...
-
Product Insights
NewRhino-Conjunctivitis – Drugs In Development, 2024
Empower your strategies with our Rhino-Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Rhinitis is characterized by one or several of the following symptoms: nasal congestion, runny nose, post-nasal drip, sneezing, red eyes (conjunctivitis), and itching of the nose or eyes. It may be allergic or non-allergic. It is important to enact environmental control measures to avoid the allergens that are causing the problem. The Rhino-Conjunctivitis drugs in development market research report provide comprehensive information on...
-
Product Insights
NewAllergic Rhino-Conjunctivitis – Drugs In Development, 2024
Empower your strategies with our Allergic Rhino-Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Allergic Rhino-Conjunctivitis is an allergen-induced inflammatory response mediated by IgE and most observed in children and most rare in children above 5 years and in adults. Allergens release by plants, herbs, pollens, animal dander, dust mites are common mediators. It is preferable to allergic rhinitis. The most common nasal symptoms are sneezing, irritability, itching, runny nose and non-nasal are redness, eye itching....
-
Product Insights
NewMalaria – Drugs In Development, 2024
Empower your strategies with our Malaria – Drugs In Development, 2024 report and make more profitable business decisions. Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malaria, and pregnant women and their unborn children. Symptoms may include fever, chills, headache, sweats, fatigue, enlarged spleen, nausea, and vomiting. Treatment includes anti-malarial medicines....
-
Product Insights
NewRespiratory Syncytial Virus (RSV) Infections – Drugs In Development, 2024
Empower your strategies with our Respiratory Syncytial Virus (RSV) Infections – Drugs In Development, 2024 report and make more profitable business decisions. Respiratory syncytial virus (RSV) infection is a respiratory disease. RSV commonly causes bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children less than one year of age. The symptoms of RSV infection include cough, stuffy or runny nose, mild sore throat, earache, and fever. Treatment includes proper medication and hygiene practice. The Respiratory Syncytial Virus...